Drug Profile
Porcine neural cell product-HD
Alternative Names: NeuroCell-HDLatest Information Update: 31 Mar 2022
Price :
$50
*
At a glance
- Originator Diacrin; Genzyme Corporation
- Developer Diacrin
- Class Neuroprotectants
- Mechanism of Action Dopaminergic cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Huntington's disease
Most Recent Events
- 17 Oct 2002 Discontinued - Phase-I for Huntington's disease in USA (Intracerebal)
- 27 Jun 2001 This product is still in active development
- 09 Jul 1998 Phase-I clinical trials for Huntington's disease in USA (Intracerebal)